Tumor immunity and cancer recurrence prediction study
Part of Cancer clinical trials.
This study looks at your immune system's role in fighting cancer and tries to predict if cancer might return after surgery. By joining, you help doctors learn more about how to prevent recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have been diagnosed with cancer (such as liver, lung, stomach, or colorectal cancer) and be scheduled to have surgery to remove it
- You must not be pregnant or breastfeeding, and agree not to become pregnant or breastfeed for the next 2 years
- You must be willing to sign a consent form after learning about the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a lab test on your tumor can better predict the chance that non-metastatic colon cancer will come back after surgery. Researchers will compare relapse risk using the Immunoscore® test to help guide follow-up and treatment decisions.
This study looks at immune cells inside lung tumors to better understand how they work. If you are having surgery for a thoracic tumor, your tissue could help researchers learn more.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This study looks for biological markers (special signs in your body) that could help doctors choose better immune-based treatments for non-small cell lung cancer. Researchers will study your tumor and blood to understand which patients might benefit most from immunotherapy.
This study looks at how certain immune cells relate to Crohn's disease coming back after bowel surgery. The goal is to better understand why some patients have a recurrence, which could help improve future treatments.
This study looks at medical records of people with a common type of early breast cancer to understand how often the cancer comes back after surgery. It helps doctors learn more about which patients might have a higher or lower risk of recurrence.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.